A randomized, double-masked, parallel-group, comparative study to evaluate the clinical efficacy and safety of 1% azithromycin–0.1% dexamethasone combination compared to 1% azithromycin alone, dexamethasone 0.1% alone, and vehicle in the treatment of subjects with blepharitis
Kamran Hosseini,1 Richard L Lindstrom,2,3 Gary Foulks,4 Kelly K Nichols5 1InSite Vision, Alameda, CA, 2Minnesota Eye Consultants, 3Department of Ophthalmology and Visual Neurosciences, University of Minnesota Medical School, Minneapolis, MN, 4Department of Ophthalmology and Vision Science, School o...
Guardado en:
Autores principales: | Hosseini K, Lindstrom RL, Foulks G, Nichols KK |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a01d9c0fb50c4a5685986f2d35951ed0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A Phase III clinical study to evaluate the efficacy of combined azithromycin and dexamethasone in the treatment of blepharoconjunctivitis
por: Hosseini K, et al.
Publicado: (2013) -
Azithromycin Attenuates Bleomycin-Induced Pulmonary Fibrosis Partly by Inhibiting the Expression of LOX and LOXL-2
por: Xiang Tong, et al.
Publicado: (2021) -
Azithromycin in DuraSite® for the treatment of blepharitis
por: Jodi Luchs
Publicado: (2010) -
Low‐Temperature Protonic Ceramic Fuel Cells through Interfacial Engineering of Nanocrystalline BaCe0.7Zr0.1Y0.1Yb0.1O3−δ Electrolytes
por: Jun Gao, et al.
Publicado: (2021) -
COMPARISON OF MONTHLY PULSE OF ORAL AZITHROMYCIN WITH DAILY DOXYCYCLINE IN THE TREATMENT OF MODERATE ACNE VULGARIS
por: Muhammad Mudassir, et al.
Publicado: (2021)